Oculus to unveil the Corvis® ST and the Pentacam® at the ESCRS

Article

Oculus will be presenting its new Corvis ST device at the ESCRS exhibition in Vienna this year.

Oculus will be presenting its new Corvis® ST device at the ESCRS exhibition in Vienna this year.

The device enables the surgeon to view the reaction of the cornea on an air impulse. This is conducted using a high-speed Scheimpflug camera and then displayed on the control panel in ultra-slow-motion.

Visiting the Oculus booth B614 will be an opportunity to learn about the device and other biomechanical properties. Oculus invites you to particpate in a satellite meeting on Monday 19th September, 1pm, in room Lehar 2 of the Messe Wien Congress Centre. Several guest speakers will be present.

Other Oculus products presented at the stand will include: the Pentacam® HR Premium edition Keratograph with tearfilm scanning, the PARK 1® 3-in-1 pachymeter, refraktometer and keratometer, the SDI®/BIOM® system, the perimeters Easyfield® and Centerfield® 2 and the slit lamp camera system ImageCam®.

For more information

Oculus website.

Click here to email Oculus

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.